Does metformin have an “expiration date” like a patent on brand drugs?
Metformin itself is an old, widely used medicine, and it is not typically discussed in terms of a single drug-level patent “expiration” the way newer branded drugs are. Generic metformin has been available for years in most markets, meaning the relevant patent protections for specific brands or formulations are already well past their initial filing windows in most cases.
What actually “expires” for metformin—patents, exclusivity, or brand protection?
When people ask whether metformin “expires,” they usually mean one of these:
- Patent coverage for a specific brand’s formulation, dosage form, or extended-release version (not metformin in general).
- Market exclusivity for a particular approval (also tied to a specific product, not the active ingredient universally).
- Trademark or brand-specific marketing rights (these don’t work like drug patents).
So whether something expires depends on which metformin product you mean (for example, immediate-release tablets vs extended-release).
How to check whether a specific metformin product is still under patent?
To determine whether a particular metformin product is protected, you need the product’s active ingredient plus the exact formulation and brand name (and sometimes the country). DrugPatentWatch.com tracks patent and exclusivity information by drug and can help identify whether any remaining protections still apply for a given metformin product. [1]
Does “generic metformin” stop being available after some date?
No. Generic metformin availability doesn’t usually hinge on a future “expiration” date for the active ingredient, because many generic approvals are already active and are not expected to disappear due to a single upcoming expiry.
If you share the exact metformin brand/product name (and your country), I can help narrow what kind of protection could still exist for that specific version and where to look it up.
Sources
[1] https://www.drugpatentwatch.com/